Vaccine News and Research

Latest Vaccine News and Research

Scientists increase potency of HIV-1 antibody, identify new ways to develop vaccines

Much like coronavirus, circulating HIV-1 viruses mutate into diverse variants that pose challenges for scientists developing vaccines to protect people from HIV/AIDS.

12 Mar 2021

COVID-19 mRNA vaccines can reduce risk of asymptomatic COVID-19 infection

Ten days after receiving a second dose of a messenger RNA, or mRNA, vaccine for COVID-19, patients without COVID-19 symptoms are far less likely to test positive and unknowingly spread COVID-19, compared to patients who have not been vaccinated for COVID-19.

12 Mar 2021

Spike protein mutations in SARS-CoV-2 variants help resist antibody neutralization

Researchers based in Beijing and Shenzhen, China, report that they have identified mutations in the spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that may allow variant strains to avoid neutralization by monoclonal antibodies and convalescent blood plasma.

11 Mar 2021

Delaying second dose of Pfizer-BioNTech SARS-CoV-2 vaccine may be feasible in some cases

Researchers in Spain have conducted the most extensive study to date investigating the effectiveness of vaccinating healthcare workers with a single dose of the Pfizer-BioNTech vaccine to protect against coronavirus disease 2019 (COVID-19).

11 Mar 2021

Study addresses glycosylation concerns in SARS-CoV-2 vaccine design

An international team of researchers has found that glycosylation patterns are conserved across the native spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19) – and the recombinant spike proteins made in laboratories for use in vaccines.

11 Mar 2021

Americans coping with pandemic stress report undesired changes to weight, increased drinking

As growing vaccine demand signals a potential turning point in the global COVID-19 pandemic, the nation's health crisis is far from over.

11 Mar 2021

NCCN publishes new guidance for management of COVID-19 in cancer patients

The National Comprehensive Cancer Network--an alliance of leading cancer centers--has published new best practice recommendations for Management of COVID-19 Infection in Patients with Cancer.

11 Mar 2021

Jobs with greater risk for COVID-19 exposure have high number of Black or Hispanic workers

Black and Hispanic people experience a higher risk for COVID-19 and severe illness, influenced by factors such as discrimination, housing, and healthcare access and utilization.

11 Mar 2021

KHN’s ‘What the Health?’: Expanding the ACA in an unpredicted way

For the first time since its enactment in 2010, the Affordable Care Act is slated for major benefit expansions, courtesy of the covid relief bill approved by Congress this week. But the changes are only temporary, so the measure also tees up a fight to make them permanent.

11 Mar 2021

People previously infected with SARS-CoV-2 may achieve immunity after one mRNA vaccine dose, finds study

A team of researchers led by Thomas W. McDade of Northwestern University suggests people who were previously infected with SARS-CoV-2, the causative agent of COVID-19, may require only one dose of the mRNA vaccine to obtain immunity.

11 Mar 2021

High obesity rates in Southern states magnify Covid threat

In January, as Mississippi health officials planned for their incoming shipments of covid-19 vaccine, they assessed the state's most vulnerable: health care workers, of course, and elderly people in nursing homes.

11 Mar 2021

Is a single mRNA COVID-19 vaccine dose enough for recovered individuals?

A new study deals with the evaluation of adaptive immune response to COVID-19 vaccination in candidates who have recovered from SARS-CoV-2 infection.

11 Mar 2021

Researchers develop assay for qualitative assessment of SARS-CoV-2 neutralizing antibodies

To address the need for a high-quality neutralization assay against SARS-CoV-2, researchers from the NIAID modified and optimized a previously established fluorescence reduction neutralization assay (FRNA) to provide a quantitative assessment of a large number of infected cells through the use of a high-content imaging system.

11 Mar 2021

Nanobody works against all SARS-CoV-2 variants of concern in animal model

Researchers based in Belgium have developed a new antibody drug that is highly successful at neutralizing coronavirus disease 2019 (COVID-19) in Syrian hamsters. The new biologic was administered to the rodents and was found to be equally successful at neutralizing the original severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) strain, and also the new mutant variants, such as the South African and UK strains.

11 Mar 2021

Danish study on the efficacy of Pfizer/BioNTech SARS-CoV-2 vaccine after first and second dose

As the coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues, many countries have rolled out vaccines against the virus. In an encouraging preprint research paper posted to the medRxiv* server, scientists report on the vaccine efficacy in the Danish vaccination program.

10 Mar 2021

South African SARS-CoV-2 variant most problematic for BNT-162b2 vaccine

Researchers from Germany and the US investigated the efficacy of neutralizing antibodies against newer variants using serum and saliva samples obtained from groups of infected, vaccinated (with Pfizer BNT-162b2), and uninfected individuals. The researchers started this study to uncover vaccine-induced immune response and show the efficiency of antibody binding and neutralization in SARS-CoV-2 variants.

10 Mar 2021

Study confirms COVID-19 vaccine rollout decreasing disease incidence across USA

By comparing vaccination rates in 580 counties across the United States with the corresponding coronavirus disease (COVID-19) incidence rates, a recent study currently available on the medRxiv preprint server finds that cumulative county-level vaccination rates are significantly associated with a concomitant fall in the incidence of COVID-19.

10 Mar 2021

Genome-wide covariation analysis sheds light on the evolution of SARS-CoV-2

Researchers in the United States have computed genome-wide covariation within severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to investigate interactions that could be of considerable importance in the prevention, diagnosis, and treatment of coronavirus disease 2019 (COVID-19).

10 Mar 2021

Mass immunization to stop Ebola outbreak in Guinea

As the first shipment of COVID-19 vaccines arrived in Africa this week, another vaccine was being rolled out in Guinea, in a bid to stop a fresh outbreak of Ebola in its tracks.

10 Mar 2021

New technology may expand health inequalities worldwide

Rich countries get vaccines first. People with high status or a lot of money are healthier and live longer. New technology could increase the disparities.

10 Mar 2021

Vaccine News and Research

Latest Vaccine News and Research

Scientists increase potency of HIV-1 antibody, identify new ways to develop vaccines

COVID-19 mRNA vaccines can reduce risk of asymptomatic COVID-19 infection

Spike protein mutations in SARS-CoV-2 variants help resist antibody neutralization

Delaying second dose of Pfizer-BioNTech SARS-CoV-2 vaccine may be feasible in some cases

Study addresses glycosylation concerns in SARS-CoV-2 vaccine design

Americans coping with pandemic stress report undesired changes to weight, increased drinking

NCCN publishes new guidance for management of COVID-19 in cancer patients

Jobs with greater risk for COVID-19 exposure have high number of Black or Hispanic workers

KHN’s ‘What the Health?’: Expanding the ACA in an unpredicted way

People previously infected with SARS-CoV-2 may achieve immunity after one mRNA vaccine dose, finds study

High obesity rates in Southern states magnify Covid threat

Is a single mRNA COVID-19 vaccine dose enough for recovered individuals?

Researchers develop assay for qualitative assessment of SARS-CoV-2 neutralizing antibodies

Nanobody works against all SARS-CoV-2 variants of concern in animal model

Danish study on the efficacy of Pfizer/BioNTech SARS-CoV-2 vaccine after first and second dose

South African SARS-CoV-2 variant most problematic for BNT-162b2 vaccine

Study confirms COVID-19 vaccine rollout decreasing disease incidence across USA

Genome-wide covariation analysis sheds light on the evolution of SARS-CoV-2

Mass immunization to stop Ebola outbreak in Guinea

New technology may expand health inequalities worldwide

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Newsletters you may be interested in